Serological and Structural Heterogeneity of HLA-DR and DQ Antigens in HLA-DR4 Homozygous B Lymphoid Cells
スポンサーリンク
概要
- 論文の詳細を見る
Titration in the ELISA assay of a panel of anti HLA class II monoclonal antibodies with homozygous HLA-DR4 B lymphoid cell lines showed that the monoclonal antibody Q2/80 displays a low titer with the cell lines expressing the HLADw15 specificity, a high titer with the cell lines expressing the HLA-DKT2 specificity and an intermediate titer with the cell lines expressing the HLA-Dw4, Dw10 and Dw14 specificities. Because of the limited and somehow conflicting information about the structural heterogeneity of HLA-DR and DQ antigens isolated from HLA-DR4 homozygous lymphoid cells expressing different HLA-D allospecificities, HLA-DR and DQ antigens were analysed by 2-dimensional gel electrophoresis (either IEF or NEPHGE in the first dimension and SDS-PAGE in the second dimensions) utilizing some of the cell lines and monoclonal antibodies utilized by other investigators. Heterogeneity was detected in the β chains but not in the α chains of HLA-DR and DQ antigens isolated from the various cell lines. Specifically the two β chains of HLA-DR antigens associated with HLA-Dw15 (referred to as β1 and β2) are more basic than those associated with HLA-DKT2 (referred to as β3 and β4). The latter two are more basic than the two β chains associated with HLA-Dw10 (referred to as β5 and β6). The two β chains associated with HLA-Dw4 and with HLA-Dw14 do not appear to differ from each other; one has the same electrophoretic mobility as β2 and the other one as β3. The HLA-D associated heterogeneity of β chains of HLA-DR antigens resides in their polypeptide moiety, since it was detected in antigens synthesized by B lymphoid cells in presence of tunicamycin as well as following removal of carbohydrates with enzymes. The electrophoretic heterogeneity of the β chains of HLA-DQ antigens was less marked than that of HLA-DR antigens, since the β chain associated with HLA-Dw15 (referred to as Qβ1) was more basic than those associated with HLA-DKT2, Dw10 and Dw14 (referred to as QB2), which did not differ from each other. The β chain associated with HLA-Dw4 consisted of both Qβ1 and Qβ2. The present study has shown for the first time serological heterogeneity among HLA-DR4 alloantigens associated with different HLA-D allospecificities. Furthermore our results suggest that the conflicting results in the literature about the structural heterogeneity of HLA-DR4 antigens may be caused by various labelling procedures and/or by the sensitivity of the 2-D electrophoretic procedure and that HLA-DR4 lymphoid cell lines with the same HLA-D allospecificity may differ in the antigenic profile or in the expression of HLA-DQ antigens.
- 北里大学の論文
- 1987-06-30
著者
-
Igarashi Muneo
Department of Pediatrics, Kitasato University School of Medicine.
-
FERRONE Soldano
Department of Immunology, Roswell Park Cancer Institute
-
Igarashi M
Kitasato Univ. School Of Medicine Jpn
-
Igarashi Muneo
Department Of Pediatrics Kitasato University School Of Medicine.
-
Ferrone S
Roswell Park Cancer Inst. Ny Usa
-
Ferrone Soldano
Department Of Immunology Roswell Park Cancer Institute
-
Kashiwagi Noboru
Department of Transplantation Immunology, Kitasato University School of Medicine, Sagamihara, Japan.
-
Kashiwagi Noboru
Department Of Transplantation Immunology Kitasato University School Of Medicine Sagamihara Japan.
関連論文
- 小児期ネフローゼ症候群の治療
- 紫斑病性腎炎の臨床病理学的検討
- Soluble human MHC class I molecules induce soluble Fas ligand secretion and trgger apoptosis in activated CD8^+ Fas (CD95)^+ T lymphocytes
- Methylprednisolone Pulse Therapy in Treatment of Renal Disease in Children; Its Suppressive Effect for Lymphocyte and Correlation in Clinical Status
- Pulse Therapy on Lupus Nephritis in Children
- Serological and Structural Heterogeneity of HLA-DR and DQ Antigens in HLA-DR4 Homozygous B Lymphoid Cells
- Anti-cow's Milk IgE Antibodies Recognize Fewer Molecules than IgG Antibodies
- HLA class I defects in malignant lesions : What have we learned?
- DETECTION OF ANTI-IDIOTYPIC ANTIBODY RESPONSIBLE FOR IMMUNOLOGICAL MAINTENANCE OF PREGNANCY